News

5 ways to keep farming stress at bay

Fall is a busy time of year, and nobody knows this better than farmers. As harvest season draws to a close, remember these simple strategies that can help you manage the stress that may follow. 1. Make the most of your healthy lifestyle choices (but don't expect perfection). Sleep is hard to come by during harvest season, when weather, moisture, equipment malfunctions and other uncontrollable factors play a major role in whether you can get a solid 8 hours of rest. So, focus on the things you can control, including your diet, alcohol intake and activity level—all of which have a direct impact
News

5 ways to keep farming stress at bay

Fall is a busy time of year, and nobody knows this better than farmers. As harvest season draws to a close, remember these simple strategies that can help you manage the stress that may follow. 1. Make the most of your healthy lifestyle choices (but don't expect perfection). Sleep is hard to come by during harvest season, when weather, moisture, equipment malfunctions and other uncontrollable factors play a major role in whether you can get a solid 8 hours of rest. So, focus on the things you can control, including your diet, alcohol intake and activity level—all of which have a direct impact
News

Domestic Violence: Resources from an OB-GYN

October is Domestic Violence Awareness Month. If you or someone you know is experiencing intimate partner violence, SIU Medicine has resources to help. Board certified in Obstetrics and Gynecology, Dr. Katherine Hild-Mosley offers guidance for patients and members of the community seeking assistance for their physical, mental and emotional well-being. Q: Can patients speak with their OB-GYN or physician if they are experiencing domestic abuse? A: Yes! A patient is encouraged to speak to her physician about any concerns she may have at any time. The American College of Obstetricians and
Trial
Neurology

Roche: A Phase IIB, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of intravenous prasinezumab in participants with early Parkinson's disease

Active not recruiting

This study will evaluate the efficacy, safety, and pharmacokinetics of prasinezumab compared with placebo in patients with early Parkinson's disease (PD).

Locations

SIU Medicine Maternal-Fetal Medicine | Quincy

612 N. 11th St. Quincy, IL 62301
Mon - Fri: 8:00 am-4:30 pm
Locations
Trial
Psychiatry

RECOVER: A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No-Stimulation Control in Subjects with Treatment-Resistant Depression

Active recruiting

The RECOVER study is a nationwide clinical trial that has been approved by Medicare to provide additional evidence for the benefits of Vagus Nerve Stimulation (VNS) Therapy.  Vagus Nerve Stimulation Therapy is an FDA-approved device for treating patients with TRD (Treatment Resistant Depression). It is implanted in the left chest area during a short outpatient procedure. The device delivers mild, intermittently pulsed signals to the vagus nerve in the neck that activate various parts of the brain.

News

SIU Medicine enrolling patients for clinical study to treat depression

SPRINGFIELD, ILLINOIS, October 18, 2021 – Clinical depression affects more than 17 million people in the United States. Among those afflicted, 1 out of 3 has what is called treatment-resistant depression (TRD). Despite medical help, they have been unable to find adequate relief from their symptoms. A new clinical trial at SIU School of Medicine is testing a treatment that could help those with recurring depression. “Depression is a common mental disorder that can become disabling if not treated,” said Jeffrey Bennett, MD, professor of psychiatry at SIU School of Medicine and the principal
News

SIU Medicine enrolling patients for clinical study to treat depression

SPRINGFIELD, ILLINOIS, October 18, 2021 – Clinical depression affects more than 17 million people in the United States. Among those afflicted, 1 out of 3 has what is called treatment-resistant depression (TRD). Despite medical help, they have been unable to find adequate relief from their symptoms. A new clinical trial at SIU School of Medicine is testing a treatment that could help those with recurring depression. “Depression is a common mental disorder that can become disabling if not treated,” said Jeffrey Bennett, MD, professor of psychiatry at SIU School of Medicine and the principal
News

SIU Medicine enrolling patients for clinical study to treat depression

SPRINGFIELD, ILLINOIS, October 18, 2021 – Clinical depression affects more than 17 million people in the United States. Among those afflicted, 1 out of 3 has what is called treatment-resistant depression (TRD). Despite medical help, they have been unable to find adequate relief from their symptoms. A new clinical trial at SIU School of Medicine is testing a treatment that could help those with recurring depression. “Depression is a common mental disorder that can become disabling if not treated,” said Jeffrey Bennett, MD, professor of psychiatry at SIU School of Medicine and the principal
Subscribe to Patient